<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0027">
 <element-citation publication-type="journal" id="sbref0027">
  <person-group person-group-type="author">
   <name>
    <surname>Chun</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>D.S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>Y.C.</given-names>
   </name>
   <name>
    <surname>Nam</surname>
    <given-names>Y.J.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>D.U.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>Y.S.</given-names>
   </name>
  </person-group>
  <article-title>Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-ÎºB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells</article-title>
  <source>International Immunopharmacology</source>
  <volume>14</volume>
  <issue>4</issue>
  <year>2012</year>
  <fpage>375</fpage>
  <lpage>383</lpage>
  <pub-id pub-id-type="doi">10.1016/j.intimp.2012.08.011</pub-id>
  <pub-id pub-id-type="pmid">22940184</pub-id>
 </element-citation>
</ref>
